Clinical Trial Update: Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of MVAC chemotherapy followed by Gemcitabine plus Cisplatin in locally advanced or metastatic bladder cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Rheumatrex (methotrexate)
• Velban (vinblastine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED